BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
-12.6%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$330M
AUM Growth
+$330M
(-16%)
Cap. Flow
+$3.14M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
39.97%
Holding
75
New
–
Increased
16
Reduced
36
Closed
4
Top Buys
| 1 |
Medtronic
MDT
|
$721K |
| 2 |
Nike
NKE
|
$279K |
| 3 |
NVIDIA
NVDA
|
$205K |
| 4 |
Honeywell
HON
|
$160K |
| 5 |
Rockwell Automation
ROK
|
$127K |
Top Sells
| 1 |
Unilever
UL
|
$882K |
| 2 |
Becton Dickinson
BDX
|
$330K |
| 3 |
Novartis
NVS
|
$325K |
| 4 |
AbbVie
ABBV
|
$318K |
| 5 |
Walmart
WMT
|
$231K |
Sector Composition
| 1 | Healthcare | 23.32% |
| 2 | Technology | 23.27% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 7.94% |
| 5 | Consumer Staples | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Nike
NKE
$110B
| $4M | 1.21% |
39,160
+2,730
| +7% | +$279K |
|
27
Edwards Lifesciences
EW
$47.7B
| $3.99M | 1.21% |
42,003
+520
| +1% | +$49.4K |
|
28
PepsiCo
PEP
$203B
| $3.98M | 1.21% |
23,875
-70
| -0.3% | -$11.7K |
|
29
Chevron
CVX
$318B
| $3.8M | 1.15% |
26,238
-1,337
| -5% | -$194K |
|
30
PayPal
PYPL
$66.5B
| $3.78M | 1.15% |
54,130
+1,114
| +2% | +$77.8K |
|
31
Exxon Mobil
XOM
$477B
| $3.07M | 0.93% |
35,889
-285
| -0.8% | -$24.4K |
|
32
Illumina
ILMN
$15.2B
| $2.81M | 0.85% |
15,262
-18
| -0.1% | -$3.41K |
|
|
33
Novartis
NVS
$248B
| $2.74M | 0.83% |
32,385
-3,848
| -11% | -$325K |
|
34
Church & Dwight Co
CHD
$22.7B
| $2.59M | 0.78% |
27,893
-65
| -0.2% | -$6.02K |
|
|
35
Medtronic
MDT
$118B
| $2.51M | 0.76% |
28,005
+8,036
| +40% | +$721K |
|
|
36
AbbVie
ABBV
$374B
| $2.03M | 0.62% |
13,237
-2,075
| -14% | -$318K |
|
37
Aptiv
APTV
$17.3B
| $1.84M | 0.56% |
20,627
+1,197
| +6% | +$107K |
|
38
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.39M | 0.42% |
30,000
| – | – |
|
39
Welltower
WELL
$112B
| $1.24M | 0.37% |
15,000
| – | – |
|
40
Ironwood Pharmaceuticals
IRWD
$201M
| $963K | 0.29% |
83,500
-12,500
| -13% | -$144K |
|
41
Bristol-Myers Squibb
BMY
$96.7B
| $901K | 0.27% |
11,700
| – | – |
|
42
3M
MMM
$81B
| $899K | 0.27% |
6,945
-250
| -3% | -$32.4K |
|
43
Intel
INTC
$105B
| $822K | 0.25% |
21,990
-5,975
| -21% | -$223K |
|
|
44
Becton Dickinson
BDX
$54.3B
| $805K | 0.24% |
3,266
-1,225
| -27% | -$330K |
|
45
Pembina Pipeline
PBA
$21.9B
| $788K | 0.24% |
22,300
-128
| -0.6% | -$4.52K |
|
46
Union Pacific
UNP
$132B
| $594K | 0.18% |
2,789
-5
| -0.2% | -$1.07K |
|
47
Thermo Fisher Scientific
TMO
$183B
| $584K | 0.18% |
1,075
| – | – |
|
48
Novo Nordisk
NVO
$252B
| $524K | 0.16% |
4,700
-100
| -2% | -$11.1K |
|
49
Trane Technologies
TT
$90.9B
| $516K | 0.16% |
3,970
| – | – |
|
50
Merck
MRK
$210B
| $516K | 0.16% |
5,650
| – | – |
|